A critical exploration into why male investors are afraid of the v‑word, what that means for women’s health and sexual wellness, and how we can overcome it.
Women make over 80% of healthcare decisions in the U.S. yet have been excluded from designing the health system. It was only 1993 when women and POC were included in clinical trials. Heart attacks are the number-one killer of women, but women are 50% more likely to be given a wrong diagnosis. Only 4% of all healthcare research is focused on women’s health issues. From periods and childbirth to menopause, female pain has been normalized, as society shrugs and says “Welcome to being a woman” instead of coming up with better solutions.
In The Vagina Business, award-winning journalist Marina Gerner Ph.D. takes an eye-opening — and often times shocking — look at the inequities when it comes to scientific research and the funding of female-focused health companies. She exposes the obstacles entrepreneurs around the world face. Most of all, she shows us that it doesn’t have to be this way.
![](/themes/custom/jbc_theme/images/logo.png)
Nonfiction
The Vagina Business: The Innovative Breakthroughs that Could Change Everything in Women’s Health
- From the Publisher
September 1, 2023
Discussion Questions
![](/sites/default/files/images/book_covers_donate.png)
Jewish literature inspires, enriches, and educates the community.
Help support the Jewish Book Council.